Announcements

  • All
  • Announcements 2009
  • Announcements 2010
  • Announcements 2011
  • Announcements 2012
  • Announcements 2017
  • Announcements 2018
  • Announcements 2019
  • Announcements 2020
  • Announcements 2021
  • Announcements 2022
  • Announcements 2024

Peania, 16 May 2023 – Lavipharm today presented its key financial results and activities to the Hellenic Fund and Asset Management Association. The presentation took place in the context of the Annual Analyst Update as per the Company’s 2023 Financial Calendar and was held at...

Paiania, 12 May 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and following relevant notification, announces that Mr. Thomas Tseronis, Head of Sales Rx, sold 35.434 Lavipharm common shares, amounting in total to €15.732,7....

Paiania, 4 May 2023 – Group Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) increased by 34% during the first quarter of 2023 and amounted to €2.46 million compared to €1.84 million during the relevant period of the previous year. Lavipharm Key Financial Figues Q1 2023...

Paiania, 27 April 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, and as part of providing accurate and timely information to the investment community, announces the amended Financial Calendar of 2023. The amendment refers to the Analysts’...

Paiania, 28 March 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and the Regulation of the Athens Exchange, announces the appointment of Mr. Evangelos Paterakis as Chief Accountant replacing Mr. Panagiotis Pavlou, who is retiring.   ###...

Peania, 15 March 2023 - Lavipharm S.A. announces the key financial figures for 2022 and business developments in its activity: Lavipharm Flash Note FY2022 ...

Peania, 6 March 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, announces the Financial Calendar of 2023, as follows : FINANCIAL CALENDAR 2023...

A new page in its presence on the stock exchange Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase,...

Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase, the Listings and Market Operation Committee of the Athens...